NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Aquilon Pharmaceuticals

Aquilon Pharmaceuticals

Private
SeraingHealthcare & Life Scienceshttps://aquilonpharma.com/

Last Round

VC Round

Jun 3, 2025

Total Funding Raised

$10.35M

Company Overview

Aquilon Pharmaceuticals is a drug discovery company that develops pharmaceutical drugs for the treatment of pulmonary diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Application

Keywords

drug formulationinhalation technologypulmonary drug deliveryrespiratory medicinebiotechasthma treatmentCOPD treatmentdrug reformulationbiobetterexcipient technologydrug delivery platformdeep lung depositionnasal sprayHP-Betadexdry powder inhalersoft mist inhaler

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Aquilon Pharmaceuticals Comparables

Compare Aquilon Pharmaceuticals with similar companies based on industry and business-model similarity.

Aquilon Pharmaceuticals comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Iconovo AB
74%
Transpire Bio Inc.
73%
Ligand Pharmaceuticals
72%

Aquilon Pharmaceuticals Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJun 3, 2025
GrantAug 1, 2023
GrantFeb 1, 2022
DebtMay 11, 2021
VC RoundNov 30, 2018
Seed
Oct 26, 2015

Key People

Founding team and executive leadership

Paul J. Maes

CEO

Executive Team

Michael LeGrand

Chief Financial Officer

Executive Team

Aquilon Pharmaceuticals Investors

Notable investors and investment history

Aquilon Pharmaceuticals investors
InvestorRounds
NoshaqVC Round
Wallonie EntreprendreGrant
BioWinGrant
SambrinvestVC Round
BeAngelsSeed, VC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 23, 2025

    Monthly visitors increased 275% MoM.

Aquilon Pharmaceuticals Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Aquilon Pharmaceuticals Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Aquilon Pharmaceuticals's valuation, stock price, and market status.

Firmographic Details

HeadquartersSeraing
Employee Range18
Year Founded2013
Last FundingJun 3, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.